Commentary on: Noninvasive assessment of liver fibrosis using aspartate transaminase to platelet ratio index (APRI) in adult patients with chronic liver disease
Main Authors: | El-Shabrawi, Mortada, Isa, Mona |
---|---|
Format: | Online |
Language: | English |
Published: |
Kowsar
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212770/ |
Similar Items
-
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
by: Adler, Michael
Published: (2011) -
Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
by: Yilmaz, Yusuf, et al.
Published: (2011) -
Commentary on: Aspartate transaminase to platelet ratio index (APRI): A simple noninvasive index assessing liver fibrosis in patients with chronic liver diseases
by: Mao, Yilei, et al.
Published: (2011) -
Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease
by: Anania, Caterina, et al.
Published: (2011) -
Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?
by: Corte, Claudia Della, et al.
Published: (2011)